BBOT

BRIDGEBIO ONCOLOGY THERAPEUT

Institutional Ownership · Q4 2025

Filing: Q4 2025

BRIDGEBIO ONCOLOGY THERAPEUT (BBOT) is held by 51 institutional investors with combined holdings of $751M. Major holders include Cormorant Asset Managemen, DEERFIELD MANAGEMENT COMP, Omega Fund Management, LL.

💰 Dark Pool Activity 👤 Insider Trades

Institutional Holders

Total Value

$750.5M

Ownership %

72.2%

🏦 Top Institutional Holders

Cormorant Asset Management, LP

17.9M shares

$223.8M

22.32% ownership

DEERFIELD MANAGEMENT COMPANY, L.P.

4.9M shares

$61.2M

6.10% ownership

Omega Fund Management, LLC

3.3M shares

$41.2M

4.11% ownership

WELLINGTON MANAGEMENT GROUP LLP

📊 Financials

Income statement, balance sheet, and cash flow from SEC filings.

🏦 Browse Funds

See complete portfolios of top hedge funds.

🎯 AI Signals

Find stocks where multiple funds are accumulating.